Clinical value of CYFRA 8/18 and TPS in the diagnosis and follow up of invasive breast cancer

Anticancer Research

Volumn 17, Issue 4 B, 1997, Pages 2963-2965

  Sutterlin M ^a   Oehler, M K ^a   Caffier, H ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Breast cancer; CYFRA 8 18; TPS; Tumor marker

Indexed keywords

CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYFRA 8 18; TISSUE POLYPEPTIDE ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

BLOOD LEVEL; BREAST CANCER; BREAST DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL;

BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; PEPTIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 1842333863     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Bahlo M, Struven D, Klapdor R: TPAcyk ELISA zur quantitativen Bestimmung des Tissue Polypeptide Antigen im Serum. Labor Medizin 16: 24-26, 1993
2. Bjorklund B, Bjorklund V: Antigenicity of pooled human malignant and normal tissue by cytoimmunological techniques: Presence of an insoluble, heat-labile tumor antigen. Int Arch Allergy 10: 153-184, 1957.
3. Bjorklund B, Bjorklund V, Wiklund B et al: A human tissue polypeptide related to cancer and placenta. In: Immunological techniques for detection of cancer (Bjorklund B, ed). Bonniers, Stockholm, 134-187, 1973.
4. Bonfrer JMG, Groeneveld EM et al: Monoclonal antibody M3 used in tissue polypeptide-specific antigen assay for the quantification of tissue polypeptide antigen recognizes keratin 18. Tumor Biol 15: 210-222, 1994.
5. Bormer OP: From TPA to specific cytokeratin assays. Tumor Biol 15: 185-187, 1994.
6. Eskelinen M, Hippelainen M et al: A prospective study of tissue polypeptide specific antigen (TPS) in breast cancer diagnosis. Anticancer Res 12(6B): 2033-2036, 1992.
7. Nicolini A, Colombini C et al: Evaluation of serum CA 15-3 determination with CEA and TPS in the postoperative follow-up of breast cancer patients. Br J Cancer 64: 154-158, 1991
8. Nicolini A, Ferdeghini M, Colizzi C: Evaluation of CEA, TPA, CA 15-3,CA 549 and TPS in the monitoring of metastatic breast cancer. J Nucl Biol Med 37: 126-133, 1993.
9. van Dalen A: TPS in breast cancer. A comparative study with carcinoembryonic antigen and CA 15-3. Tumor Biol 13: 10-17, 1992.
10. van Dalen A, Heering KJ et al: Treatment response in metastatic breast cancer. A multicenter study comparing UICC criteria and tumour marker changes. Breast, (in press).